NIM1K

Across TCGA pan-cancer cohorts, NIM1K mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NIM1K data layer compared with 20 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NIM1K mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NIM1K expression acts as an unfavorable survival marker.

HNSC are the cancer types where NIM1K mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	IV	0.425	0.900	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

NIM1K–HNSC (DFS)

Open the HNSC breakdown →